Although statins are powerful lipid-lowering drugs, many patients with hypercholesterolemia do not reach current treatment goals with statin treatment. Ezetimibe the first approved direct ...

FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.

Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...

“The approved drugs, alirocumab and evolocumab, reduce LDL cholesterol by about 60% alone and up to 85% when combined with ...

Other medications could interact with your ... These alternatives to statins also have side effects. Ezetimibe blocks cholesterol absorption in your gut, which can cause diarrhea or stomach ...

The partners released late last year promising phase III data showing their drug alirocumab worked well as a monotherapy – lowering LDL cholesterol three times more than Merck's Zetia (ezetimibe ...

Searching for effective treatment options for 'High Cholesterol symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...

Researchers are mindful of the exciting days when new drugs raised “good” cholesterol, or HDL, but found they didn’t lower the risk of a heart attack or stroke, says Stephen Nicholls ...

Ezetimibe is a novel drug used for the inhibition of intestinal cholesterol absorption. It effectively reduces cholesterol absorption by approximately 54%, leading to a reduction in LDL ...